Hecla Mining outlines medium-term silver production potential above 20 million ounces
Bitget2026/11/09 18:07- Hecla Mining outlined silver output potential above 20 million ounces over the medium term at the RBC Precious Metals Conference.
- Production guidance for 2026 is 15,300,000-16,100,000 ounces; medium-term growth depends on Keno Hill's ramp-up and a Midas restart.
- Keno Hill throughput will fall to about 300 tons daily in fourth-quarter 2026, with further reductions from January 2027 pending permits and infrastructure.
- Greens Creek's proposed pyrite concentrate circuit could add 1,000,000-1,200,000 ounces of silver annually once fully ramped up.
- Intermittent production is targeted for late 2027; full capacity is expected in late 2028, subject to investment approval.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
Itaúsa Q3 2026 recurring net profit rises 25% to R$ 5.06 billion year-on-year
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.